You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Illumina said it plans to pursue a permanent injunction against BGI in the UK until the four patents expire — three in 2023 and one in 2027.
In their complaint the plaintiffs claimed Illumina fraudulently obtained two US patents by concealing a reference from the patent office.
The kit, developed by BGI Patho-Genesis Pharmaceutical Technology, is designed to construct a metagenomic sequencing library directly from clinical samples.
The Zoonomia Project and the Bird 10,000 Genomes Project have reported new genome sequences that could inform conservation and other efforts.
News items for the week of Sept. 28, 2020
Both RT-PCR tests are for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B from throat swab samples.
BGI will have a chance to depose up to nine inventors of patents assigned to Illumina as part of a lawsuit over IP related to sequencing-by-synthesis chemistry.
Sweden's public health authority says BGI's COVID-19 test returned thousands of false positive results, according to Reuters.
News items for the week of August 10, 2020.
The US Commerce Department has placed two BGI Group subsidiaries on a list of entities it suspects of human rights violations, allegations the company denies, Reuters reports.
SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.
The New York Times reports that a new viral variant of concern has been identified in New York City.
In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.
According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.